EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

The Immune Microenvironment in Prostate Cancer: A Comprehensive Review

Rene Novysedlak, Miray Guney, Majd Al Khouri, Robin Bartolini, Lily Koumbas Foley, Iva Benesova, Andrej Ozaniak, Vojtech Novak, Stepan Vesely, Pavel Pacas, Tomas Buchler, Zuzana Ozaniak Strizova

Oncology · 09.10.2024 · 103 (6) · 521-545

DOI: 10.1159/000541881 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oncology, online erschienen am 09.10.2024. Verfasst von Rene Novysedlak und 11 weiteren Autor:innen. Beteiligte Einrichtung: Third Department of Surgery, 1st Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czechia. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Tumor Microenvironment. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 224 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Prostate cancer (PCa) is a malignancy with significant immunosuppressive properties and limited immune activation. This immunosuppression is linked to reduced cytotoxic T cell activity, impaired antigen presentation, and elevated levels of immunosuppressive cytokines and immune checkpoint molecules. Studies demonstrate that cytotoxic CD8+ T cell infiltration correlates with improved survival, while increased regulatory T cells (Tregs) and tumor-associated macrophages (TAMs) are associated with worse outcomes and therapeutic resistance. Th1 cells are beneficial, whereas Th17 cells, producing interleukin-17 (IL-17), contribute to tumor progression. Tumor-associated neutrophils (TANs) and immune checkpoint molecules, such as PD-1/PD-L1 and T cell immunoglobulin-3 (TIM-3) are also linked to advanced stages of PCa. Chemotherapy holds promise in converting the “cold” tumor microenvironment (TME) to a “hot” one by depleting immunosuppressive cells and enhancing tumor immunogenicity. Summary: This comprehensive review examines the immune microenvironment in PCa, focusing on the intricate interactions between immune and tumor cells in the TME. It highlights how TAMs, Tregs, cytotoxic T cells, and other immune cell types contribute to tumor progression or suppression and how PCa’s low immunogenicity complicates immunotherapy. Key Messages: The infiltration of cytotoxic CD8+ T cells and Th1 cells correlates with better outcomes, while elevated T regs and TAMs promote tumor growth, metastasis, and resistance. TANs and natural killer (NK) cells exhibit dual roles, with higher NK cell levels linked to better prognoses. Immune checkpoint molecules like PD-1, PD-L1, and TIM-3 are associated with advanced disease. Chemotherapy can improve tumor immunogenicity by depleting T regs and myeloid-derived suppressor cells, offering therapeutic promise.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsTumor MicroenvironmentHumansMaleT-Lymphocytes, RegulatoryTumor-Associated MacrophagesImmunotherapy

Stichwörter der Autor:innen

CD4CD8ImmunologyImmunotherapyMetastaticMyeloid-derived suppressor cellsNeutrophilsProstate tumorT cellsTertiary lymphoid structuresTumor-associated macrophages

Autor:innen und Institutionen

  • Third Department of Surgery, 1st Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czechia.
  • Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czechia.
  • Lausanne Center for Immuno-oncology Toxicities (LCIT), Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Chemokine Research Group, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
  • Department of Immunology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czechia.
  • Department of Urology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czechia.

Zitieren

APA

Novysedlak, R., Guney, M., Al Khouri, M., Bartolini, R., Koumbas Foley, L., Benesova, I., Ozaniak, A., Novak, V., Vesely, S., Pacas, P., Buchler, T., & Ozaniak Strizova, Z. (2024). The Immune Microenvironment in Prostate Cancer: A Comprehensive Review. Oncology, 103(6), 521-545. https://doi.org/10.1159/000541881

Vancouver

Novysedlak R, Guney M, Al Khouri M, Bartolini R, Koumbas Foley L, Benesova I, et al. The Immune Microenvironment in Prostate Cancer: A Comprehensive Review. Oncology. 2024;103(6):521-545. doi:10.1159/000541881

BibTeX
@article{Novysedlak2024,
  author = {Novysedlak, Rene and Guney, Miray and Al Khouri, Majd and Bartolini, Robin and Koumbas Foley, Lily and Benesova, Iva and Ozaniak, Andrej and Novak, Vojtech and Vesely, Stepan and Pacas, Pavel and Buchler, Tomas and Ozaniak Strizova, Zuzana},
  title = {The Immune Microenvironment in Prostate Cancer: A Comprehensive Review},
  journal = {Oncology},
  year = {2024},
  volume = {103},
  number = {6},
  pages = {521--545},
  doi = {10.1159/000541881}
}
Kostenlos starten →